Showing results (31-40 of 47) with videos related to
Sort By:
Pageof 5
Journal of Immunology (Baltimore, Md. : 1950)|October 31, 1997
Differential effects of B7-1 blockade in the rat experimental autoimmune encephalomyelitis modelL Gallon, A Chandraker, S Issazadeh, et al.The Journal of Cell Biology|December 1, 1995
Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exonsK L Bennett, B Modrell, B Greenfield, et al.Infection and Immunity|November 18, 2000
Bacterial pathogens induce abscess formation by CD4(+) T-cell activation via the CD28-B7-2 costimulatory pathwayA O Tzianabos, A Chandraker, W Kalka-Moll, et al.The Journal of Cell Biology|February 1, 1995
CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factorK L Bennett, D G Jackson, J C Simon, et al.The Journal of Clinical Investigation|March 11, 2000
CD28-B7 blockade prevents the development of experimental autoimmune glomerulonephritisJ Reynolds, F W Tam, A Chandraker, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 20, 2000
B7 requirements for primary and secondary protein- and polysaccharide-specific Ig isotype responses to Streptococcus pneumoniaeZ Q Wu, A Q Khan, Y Shen, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1997
CD28-B7 T cell costimulatory blockade by CTLA4Ig in sensitized rat recipients: induction of transplantation tolerance in association with depressed cell-mediated and humoral immune responsesK Onodera, A Chandraker, M Schaub, et al.Proceedings of the National Academy of Sciences of the United States of America|May 1, 1990
Hypermutability of CpG dinucleotides in the propeptide-encoding sequence of the human albumin geneS O Brennan, K Arai, J Madison, et al.The Journal of Biological Chemistry|June 23, 1995
Binding stoichiometry of the cytotoxic T lymphocyte-associated molecule-4 (CTLA-4). A disulfide-linked homodimer binds two CD86 moleculesP S Linsley, S G Nadler, J Bajorath, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1996
Ex vivo treatment of antigen-presenting cells with CTLA4Ig and encephalitogenic peptide prevents experimental autoimmune encephalomyelitis in the Lewis ratS J Khoury, L Gallon, R R Verburg, et al.Pageof 5